162 related articles for article (PubMed ID: 31679112)
21. Quality of Life in a Hospice: A Validation of the Croatian Version of the EORTC QLQ-C15-PAL.
Golčić M; Dobrila-Dintinjana R; Golčić G; Pavlović-Ružić I; Stevanović A; Gović-Golčić L
Am J Hosp Palliat Care; 2018 Aug; 35(8):1085-1090. PubMed ID: 29466864
[TBL] [Abstract][Full Text] [Related]
22. Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With
Strosberg J; Wolin E; Chasen B; Kulke M; Bushnell D; Caplin M; Baum RP; Kunz P; Hobday T; Hendifar A; Oberg K; Sierra ML; Thevenet T; Margalet I; Ruszniewski P; Krenning E;
J Clin Oncol; 2018 Sep; 36(25):2578-2584. PubMed ID: 29878866
[TBL] [Abstract][Full Text] [Related]
23. What QLQ-C15-PAL Symptoms Matter Most for Overall Quality of Life in Patients With Advanced Cancer?
Caissie A; Culleton S; Nguyen J; Zhang L; Zeng L; Holden L; Dennis K; Chan E; Jon F; Tsao M; Danjoux C; Sahgal A; Barnes E; Koo K; Chow E
World J Oncol; 2011 Aug; 2(4):166-174. PubMed ID: 29147243
[TBL] [Abstract][Full Text] [Related]
24. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
[TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma.
Field KM; King MT; Simes J; Espinoza D; Barnes EH; Sawkins K; Rosenthal MA; Cher L; Hovey E; Wheeler H; Nowak AK
J Neurooncol; 2017 Jul; 133(3):623-631. PubMed ID: 28534153
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the EORTC QLQ-C15-PAL and the FACIT-Pal for assessment of quality of life in patients with advanced cancer.
Lien K; Zeng L; Nguyen J; Cramarossa G; Culleton S; Caissie A; Lutz S; Chow E
Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):541-7. PubMed ID: 21958099
[TBL] [Abstract][Full Text] [Related]
27. Quality of Life in Patients Treated with Palliative Radiotherapy for Advanced Lung Cancer and Lung Metastases.
Koo K; Zeng L; Jon F; Chen E; Dennis K; Holden L; Zhang L; Caissie A; Nguyen J; Tsao M; Barnes E; Danjoux C; Sahgal A; Chow E
World J Oncol; 2011 Apr; 2(2):70-75. PubMed ID: 29147227
[TBL] [Abstract][Full Text] [Related]
28. The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: results of the randomised controlled phase 2 BELOB trial.
Dirven L; van den Bent MJ; Bottomley A; van der Meer N; van der Holt B; Vos MJ; Walenkamp AM; Beerepoot LV; Hanse MC; Reijneveld JC; Otten A; de Vos FY; Smits M; Bromberg JE; Taal W; Taphoorn MJ;
Eur J Cancer; 2015 Jul; 51(10):1321-30. PubMed ID: 25899986
[TBL] [Abstract][Full Text] [Related]
29. Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30.
Chiu L; Chiu N; Zeng L; Zhang L; Popovic M; Chow R; Lam H; Poon M; Chow E
Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):831-7. PubMed ID: 23252363
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Patient Self-Reported Quality of Life and Health Care Professional-Assessed Symptoms in Terminally ill Patients With Cancer.
Matsumura C; Koyama N; Sako M; Kurosawa H; Nomura T; Eguchi Y; Ohba K; Yano Y
Am J Hosp Palliat Care; 2021 Mar; 38(3):283-290. PubMed ID: 32705893
[TBL] [Abstract][Full Text] [Related]
31. Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial.
Ettl J; Quek RGW; Lee KH; Rugo HS; Hurvitz S; Gonçalves A; Fehrenbacher L; Yerushalmi R; Mina LA; Martin M; Roché H; Im YH; Markova D; Bhattacharyya H; Hannah AL; Eiermann W; Blum JL; Litton JK
Ann Oncol; 2018 Sep; 29(9):1939-1947. PubMed ID: 30124753
[TBL] [Abstract][Full Text] [Related]
32. Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice.
Erharter A; Giesinger J; Kemmler G; Schauer-Maurer G; Stockhammer G; Muigg A; Hutterer M; Rumpold G; Sperner-Unterweger B; Holzner B
J Pain Symptom Manage; 2010 Feb; 39(2):219-29. PubMed ID: 20152586
[TBL] [Abstract][Full Text] [Related]
33. Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22.
McDonald R; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar R; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
Support Care Cancer; 2016 Dec; 24(12):4871-4878. PubMed ID: 27465049
[TBL] [Abstract][Full Text] [Related]
34. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
Raman S; Ding K; Chow E; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; Haas R; Wiggenraad R; Babington S; Demas WF; Wilson CF; Wong RKS; Zhu L; Brundage M
Qual Life Res; 2018 Apr; 27(4):1089-1098. PubMed ID: 29188483
[TBL] [Abstract][Full Text] [Related]
35. Do elderly patients with metastatic cancer have worse quality of life scores?
Koo K; Zeng L; Chen E; Zhang L; Culleton S; Dennis K; Caissie A; Nguyen J; Holden L; Jon F; Tsao M; Barnes E; Danjoux C; Sahgal A; Chow E
Support Care Cancer; 2012 Sep; 20(9):2121-7. PubMed ID: 22081058
[TBL] [Abstract][Full Text] [Related]
36. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
Taphoorn MJ; Claassens L; Aaronson NK; Coens C; Mauer M; Osoba D; Stupp R; Mirimanoff RO; van den Bent MJ; Bottomley A;
Eur J Cancer; 2010 Apr; 46(6):1033-40. PubMed ID: 20181476
[TBL] [Abstract][Full Text] [Related]
37. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
[TBL] [Abstract][Full Text] [Related]
38. Reliability and validity of the Turkish version of the EORTC QLQ-C15-PAL for patients with advanced cancer.
Ozcelik H; Guzel Y; Sonmez E; Aksoy F; Uslu R
Palliat Support Care; 2016 Dec; 14(6):628-634. PubMed ID: 27068607
[TBL] [Abstract][Full Text] [Related]
39. Validation of the Mexican-Spanish version of the EORTC QLQ-C15-PAL questionnaire for the evaluation of health-related quality of life in patients on palliative care.
Suárez-del-Real Y; Allende-Pérez S; Alférez-Mancera A; Rodríguez RB; Jiménez-Toxtle S; Mohar A; Oñate-Ocaña LF
Psychooncology; 2011 Aug; 20(8):889-96. PubMed ID: 20662106
[TBL] [Abstract][Full Text] [Related]
40. External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma.
Taunk NK; Moraes FY; Escorcia FE; Mendez LC; Beal K; Marta GN
Expert Rev Anticancer Ther; 2016; 16(3):347-58. PubMed ID: 26781426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
